非酒精性脂肪性肝病与膳食炎症指数的关系及现实意义

郭艳; 黄利; 杨国超; 刘珊; 杜林娜; 王敏娟

doi:10.3969/j.issn.1001-5256.2019.10.042

非酒精性脂肪性肝病与膳食炎症指数的关系及现实意义

DOI: 10.3969/j.issn.1001-5256.2019.10.042

西安医学院西安医学院第一附属医院全科

详细信息

中图分类号: R575.5
计量
- 文章访问数: 1199
- HTML全文浏览量: 20
- PDF下载量: 249
- 被引次数: 0
出版历程
- 收稿日期: 2019-05-05
- 出版日期: 2019-10-20

Association between nonalcoholic fatty liver disease and dietary inflammation index and its practical significance

Xi'an Medical University，Department of General Medicine,The First Affiliated Hospital of Xi'an Medical University

摘要

摘要: 近年来,非酒精性脂肪性肝病(NAFLD)的发病率不断攀升,且逐渐呈低龄化发展态势,包括不良饮食选择在内的不健康的生活方式是其主要诱因之一。但是,目前NAFLD的治疗方案尚不确切,以体质量减轻为目标的生活方式干预依然是治疗NAFLD最成熟的方法。研究表明,慢性炎症反应贯穿着NAFLD发生发展的全过程,而饮食在炎症级联的发展和调节中发挥着重要作用。膳食炎症指数是用于评估个人饮食结构中的炎症潜能的有效工具,自开发以来不断完善,现已广泛应用于多种疾病的临床研究中。探讨了NAFLD与膳食炎症指数的相关性,以期从饮食结构上对NAFLD进行一级预防,降低NAFLD的发病率。
- 非酒精性脂肪性肝病 /
- 膳食炎症指数 /
- 炎症 /
- 膳食,疗法
Abstract: In recent years,the incidence rate of nonalcoholic fatty liver disease(NAFLD) keeps increasing,and the age of onset gradually becomes younger. Unhealthy lifestyle,including bad dietary choices,is one of the major causes of NAFLD. However,there are still no clear treatment regimens for NAFLD,and lifestyle intervention with the aim of weight loss is still the most mature method for the treatment of NAFLD. Studies have shown that chronic inflammatory response runs through the whole process of the development and progression of NAFLD,and diet plays an important role in the development and regulation of inflammatory cascade. Dietary inflammation index(DII) is an effective tool for assessing inflammatory potential in individual dietary structure,and since its development,it has been continuously improved and is now widely used in the clinical research on many diseases. This article discusses the association between NAFLD and DII,in order to achieve primary prevention of NAFLD from dietary structure and reduce the incidence rate of NAFLD.
- non-alcoholic fatty liver disease /
- dietary inflammation index /
- inflammation /
- diet therapy

HTML全文

参考文献(36)

[1] ALISI A,CARPINO G,OLIVEIRA FL,et al. The role of tissue macrophage-mediated inflammation on NAFLD pathogenesis and its clinical implications[J]. Mediators Inflamm,2017,2017:8162421.

[2] FENG G,NIU CY. Advances in the treatment of nonalcoholic fatty liver disease[J]. J Clin Hepatol,2017,33(12):2433-2438.(in Chinese)冯巩,牛春燕.非酒精性脂肪性肝病的治疗进展[J].临床肝胆病杂志,2017,33(12):2433-2438.

[3] RINELLA ME. Nonalcoholic fatty liver disease:A systematic review[J]. JAMA,2015,313(22):2263-2273.

[4] DIEHL AM,DAY C. Cause,Pathogenesis,and treatment of nonalcoholic steatohepatitis[J]. N Engl J Med,2017,377(21):2063-2072.

[5] YOUNOSSI ZM,KOENIG AB,ABDELATIF D,et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes[J]. Hepatology,2016,64(1):73-84.

[6] ZHU JZ,ZHOU QY,WANG YM,et al. Prevalence of fatty liver disease and the economy in China:A systematic review[J].World J Gastroenterol,2015,21(18):5695-5706.

[7] WONG VW,CHAN WK,CHITTURI S,et al. Asia-Pacific Working Party on non-alcoholic fatty liver disease guidelines2017-Part 1:Definition,risk factors and assessment[J]. J Gastroenterol Hepatol,2018,33(1):70-85.

[8] BOUZIANAS DG,BOUZIANA SD,HATZITOLIOS AI. Potential treatment of human nonalcoholic fatty liver disease with longchain omega-3 polyunsaturated fatty acids[J]. Nutr Rev,2013,71(11):753-771.

[9] BUZZETTI E,PINZANI M,TSOCHATZIS EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease(NAFLD)[J]. Metabolism,2016,65(8):1038-1048.

[10] RAMALLAL R,TOLEDO E,MARTNEZ JA,et al. Inflammatory potential of diet,weight gain,and incidence of overweight/obesity:The SUN cohort[J]. Obesity(Silver Spring),2017,25(6):997-1005.

[11] HAAS JT,FRANCQUE S,STAELS B. Pathophysiology and mechanisms of nonalcoholic fatty liver disease[J]. Annu Rev Physiol,2016,78:181-205.

[12] AHLUWALIA N,ANDREEVA VA,KESSE-GUYOT E,et al.Dietary patterns,inflammation and the metabolic syndrome[J]. Diabetes Metab,2013,39(2):99-110.

[13] PARK SY,KANG M,WILKENS LR,et al. The dietary inflammatory index and all-cause,cardiovascular disease,and cancer mortality in the multiethnic cohort study[J]. Nutrients,2018,10(12):1844.

[14] SHIVAPPA N,STECK SE,HUSSEY JR,et al. Inflammatory potential of diet and all-cause,cardiovascular,and cancer mortality in National Health and Nutrition Examination Survey III Study[J]. Eur J Nutr,2017,56(2):683-692.

[15] SHIVAPPA N,STECK SE,HURLEY TG,et al. Designing and developing a literature-derived,population-based dietary inflammatory index[J]. Public Health Nutr,2014,17(8):1689-1696.

[16] HBERT JR,SHIVAPPA N,WIRTH MD,et al. Perspective:The dietary inflammatory index(DII)-lessons learned,improvements made,and future directions[J]. Adv Nutr,2019,10(2):185-195.

[17] SHIVAPPA N,HBERT JR,POLESEL J,et al. Inflammatory potential of diet and risk for hepatocellular cancer in a case-control study from Italy[J]. Br J Nutr,2016,115(2):324-331.

[18] WANG XY,FANG AP,CHEN PY,et al. High dietary inflammatory index scores are associated with an elevated risk of hepatocellular carcinoma in a case-control study[J]. Food Funct,2018,9(11):5832-5842.

[19] SHIVAPPA N,HBERT JR,STECK SE,et al. Dietary inflammatory index and odds of colorectal cancer in a case-control study from Iran[J]. Asian Pac J Cancer Prev,2018,19(7):1999-2006.

[20] SHIVAPPA N,HBERT JR,JALILPIRAN Y,et al. Association between dietary inflammatory index and prostate cancer in Shiraz province of Iran[J]. Asian Pac J Cancer Prev,2018,19(2):415-420.

[21] SHIVAPPA N,HBERT JR,PADDOCK LE,et al. Dietary inflammatory index and ovarian cancer risk in a New Jersey case-control study[J]. Nutrition,2018,46:78-82.

[22] FRITH E,SHIVAPPA N,MANN JR,et al. Dietary inflammatory index and memory function:Population-based national sample of elderly Americans[J]. Br J Nutr,2018,119(5):552-558.

[23] HUANG WQ,MO XF,YE YB,et al. A higher Dietary Inflammatory Index score is associated with a higher risk of breast cancer among Chinese women:A case-control study[J]. Br J Nutr,2017,117(10):1358-1367.

[24] SHIVAPPA N,GODOS J,HBERT JR,et al. Dietary inflammatory index and cardiovascular risk and mortality—a Metaanalysis[J]. Nutrients,2018,10(2):200.

[25] NAMAZI N,LARIJANI B,AZADBAKHT L. Dietary inflammatory index and its association with the risk of cardiovascular diseases,metabolic syndrome,and mortality:A systematic review and Meta-analysis[J]. Horm Metab Res,2018,50(5):345-358.

[26] O'NEIL A,SHIVAPPA N,JACKA FN,et al. Pro-inflammatory dietary intake as a risk factor for CVD in men:A 5-year longitudinal study[J]. Br J Nutr,2015,114(12):2074-2082.

[27] SAGHAFI-ASL M,AMIRI P,NAGHIZADEH M,et al. Association of endotoxaemia with serum free fatty acids in metabolically healthy and unhealthy abdominally obese individuals:A case-control study in northwest of Iran[J]. BMJ Open,2017,7(5):e015910.

[28] NEUFCOURT L,ASSMANN KE,FEZEU LK,et al. Prospective association between the dietary inflammatory index and metabolic syndrome:Findings from the SU. VI. MAX study[J].Nutr Metab Cardiovasc Dis,2015,25:988-996.

[29] BERGHEIM I,WEBER S,VOS M,et al. Antibiotics protect againstfructose-induced hepatic lipid accumulation in mice:Role of endotoxin[J]. J Hepatol,2008,48(6):983-992.

[30] MAZIDI M,SHIVAPPA N,WIRTH MD,et al. Diet with greater inflammatory potential is associated with higher prevalence of fatty liver among US adults[J]. Eur J Clin Nutr,2018.[Epub ahead of print]

[31] RYAN MC,ITSIOPOULOS C,THODIS T,et al. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease[J]. J Hepatol,2013,59(1):138-143.

[32] CANTERO I,ABETE I,BABIO N,et al. Dietary Inflammatory index and liver status in subjects with different adiposity levels within the PREDIMED trial[J]. Clin Nutr,2018,37(5):1736-1743.

[33] European Association for the Study of the Liver(EASL),European Association for the Study of Diabetes(EASD),European Association for the Study of Obesity(EASO). EASL-EASDEASO clinical practice guidelines for the management of nonalcoholic fatty liver disease[J]. J Hepatol,2016,64(6):1388-1402.

[34] ZELBER-SAGI S,SALOMONE F,MLYNARSKY L. The Mediterranean dietary pattern as the diet of choice for NAFLD; evidence and plausible mechanisms[J]. Liver Int,2017,37(7):936-949.

[35] LEONI S,TOVOLI F,NAPOLI L,et al. Current guidelines for the management of non-alcoholic fatty liver disease:A systematic review with comparative analysis[J]. World J Gastroenterol,2018,24(30):3361-3373.

[36] NIU HY,LI H,DING YP. Advances in the treatment of nonalcoholic fatty liver disease[J]. J Clin Hepatol,2018,34(2):433-437.(in Chinese)牛海艳,李海,丁玉平.非酒精性脂肪性肝病的治疗进展[J].临床肝胆病杂志,2018,34(2):433-437.

施引文献

资源附件(0)

访问统计